12 August 2024 Halda Therapeutics Secures $126 Million Financing to Advance RIPTAC™ Cancer Therapies into the Clinic for Major Solid Tumors read more
23 July 2024 Third Arc Bio Launches with Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors and Inflammatory & Immunology (I&I) Diseases read more
16 July 2024 Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline read more
21 May 2024 Aktis Oncology enters into Strategic Collaboration with Lily to Discover and Develop Novel Anticancer Radiopharmaceuticals read more
